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The programmed cell death ligand 1 (PD-L1) protein has emerged as a predictive cancer 
biomarker for sensitivity to immune checkpoint blockade-based cancer immunotherapies. 
Current technologies for the detection of protein-based biomarkers, including the enzyme-linked 
immunosorbent assay (ELISA), have limitations such as low sensitivity and limit of detection 
(LOD) and in addition to degradation of antibodies in exposure to environmental changes such as 
temperature and pH. To address these issues, we have proposed a metal-organic framework 
(MOF)-based ELISA for the detection of the PD-L1. A protective coating based on Zeolitic 
Imidazolate Framework 8 (ZIF-8) MOF thin film and polydopamine-polyethyleneimine (PDA-
PEI) was introduced on an ELISA plate for the improvement of antibody immobilization. 
Sensitivity and LOD of the resulting platform was compared with a conventional ELISA kit, and 
the bioactivity of the antibody in the proposed immunoassay was investigated in response to 
various pH and temperature. The LOD and sensitivity of the MOF-based PD-L1 ELISA was 225 
and 15.12 times higher, respectively, compared with that of the commercial ELISA kit. The 
antibody@ZIF-8/PDA-PEI was stable up to 55°C and a pH range of 5-10. The proposed 
platform can provide sensitive detection for target proteins, in addition to be resistant to elevated 
temperature and pH. The proposed MOF-based ELISA has significant potential for the clinical 
and diagnostic studies.
Keywords: Metal-Organic Framework; ZIF-8; PD-L1; Enzyme-linked immunosorbent assay; 
Limit of Detection.
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In the past decades, the socioeconomics burden of diseases, including cancer, has rapidly 
increased. To reduce this burden, fast and accurate diagnosis plays an important role in early 
detection and hence the treatment of diseases. Therefore, the demand for novel diagnostic 
technologies that benefit from high specificity and sensitivity to accompany clinical diagnosis 
has been increased.1 One of the most straightforward approaches for screening cancer patients is 
the detection and measurement of protein biomarker levels in biological samples, e.g., blood. 
Owing to the complexity and heterogeneity of cancer, rapid and accurate measurement of protein 
biomarkers is a challenging issue that requires further investigation.2
The programmed cell death-1/programmed cell death ligand-1 (PD-1/PD-L1) signaling pathway 
has been shown to play a crucial role in tumor immune invasion.3 The PD-1 protein is a 
checkpoint co-inhibitory receptor expressed on the surface of immune cells. Under normal 
circumstances, PD-1 causes a negative feedback mechanism that leads to switching off the 
activation of T cells. This phenomenon prevents tissue-damaging during stimulation of the 
immune system.4 The PD-L1 protein on the surface of tumor cells (or antigen-presenting cells, 
dendritic cells, and macrophages) could directly bind to PD-1. This process limits the activation 
and proliferation of T cells and weakens their cytotoxicity against tumor cells.5, 6 This 
mechanism is known for tumor immune escape,5, 6 which makes the expression level of PD-L1 
an important immune checkpoint.7 
The detection of PD-L1 and the measurement of its expression level have demonstrated 
significant potential for monitoring cancer progression and response to immunotherapy. Current 
immunoassay technologies for the cancer biomarker detection, including the enzyme-linked 
immunosorbent assay (ELISA) are accurate and simple.8 Despite the current progress in the 
development of immunosensors, microfluidic and point-of-care technologies, ELISA has been 
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identified as a gold standard and is the most widely used immunoassay technique for detecting 
and measuring disease biomarkers.9 However, there are some inevitable limitations in the use of 
ELISA, including limited sensitivity,10 which requires novel strategies to improve the ELISA 
limit of detection (LOD) and the need for reagents with high specific affinity, such as 
monoclonal antibodies (mAbs), that are not only expensive but also suffer from quality 
variations during production.11 Moreover, antibodies can degrade owing to temperature changes, 
corrosion from chemical reagents, and other perturbation conditions, which consequently affects 
the efficiency of the immunoassay.12 Therefore, stringent storage conditions (e.g., refrigeration at 
4°C) are usually required to maintain their stability. 
Several strategies have been developed to improve the performance of traditional ELISA13. 
Nanotechnology has provided a significant number of solutions. The most common strategies 
that are currently used to functionalize antibodies onto nanoparticles are covalent immobilization 
or direct physical adsorption .14 
During the last three decades, a wide range of antibody (Ab) immobilization chemistries have 
been developed through novel lab-on-a-chip technologies and biosensors, which has enhanced 
the performance of immunoassays.15 The performance of an immunoassay critically depends on 
the characteristics of the immobilized Ab because the detection sensitivity, reproducibility, 
robustness, and other bioanalytical parameters depend on the immobilization step. Therefore, the 
development of suitable strategy for immobilization of antibodyis a critical requirement that 
would affect the analytical performance of an immunoassay significantly.16 
Various antibody immobilization methods have been employed for the preparation of 
immunoassays, including covalent/noncovalent bonding, oriented, site-specific, peptide nucleic 
acid (PNA)- as well as DNA-directed, and recombinant antibody binding.16 However, the 
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immobilization of antibodies limits their movement, which could affect their three-dimensional 
conformation. These immobilization techniques suffer from critical limitations including random 
antibody orientation, nonspecific binding, low stability, uncontrolled immobilized-antibody 
density, antibody denaturation and conformation change, reduced antibody functional activity, 
and the need for extra reagents including cross-linkers, fragment crystallizable (Fc)-binding 
proteins, custom manufactured recombinant antibodies, and bioconjugate DNA/PNA.16
A metal–organic framework (MOF) is a kind of hybrid material containing metal ions or clusters 
coordinated to organic linkers. It possesses a large surface area, high porosity in addition to a 
tunable pore size.17 These features make MOFs suitable candidates in various applications 
including catalysis,18 gas storage,19 sensors,20 and functional devices.21 MOFs as a tool for the 
encapsulation of biomolecules has been a matter of research studies in recent years.22, 23 It has 
been shown that enzymes encapsulated in a MOF show limited structural changes, leading to 
maintenance of the biological function of the enzyme even under denaturing conditions.24 Naik 
and co-workers investigated the effect of MOF coatings on the preservation of the biorecognition 
capability of bio-conjugated antibodies after exposure to high temperatures (40°C and 60°C). 
They found that the stability of antibodies was improved in a wide temperature range, which 
might be practical for the fabrication of antibody-based biochips.25 The porous structure of 
MOFs could potentially protect the biomolecules from environmental conditions and improve 
their activity. MOFs-based biomineralization has been used for the transport, storage, sensing, 
and treatment of cargos including biomolecules, biological catalysts, and living organisms.26
Despite the many available strategies for ELISA fabrication, for the first time, we have 
introduced the application of MOFs for the fabrication of an ELISA platform. MOFs  have 
possessed nanoporous system with thermal stability and tunable physicochemical properties. 
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Furthermore, MOFs can be introduced as a host for encapsulation of biomolecules due to their 
ability to protect the biomolecules from rigorous environments and protect their biological 
functions 27. Moreover, due to a unique composition, diverse structures, and tunable size MOFs 
are an excellent alternative for novel immunoassay 28. The MOF-based polymeric nanoparticles 
provide the large surface-to-volume ratios which promote the efficient immobilization of 
antibodies on the nanoscale surface that consequently increase the capture efficiency of substrate 
surfaces. 
Herein, a new strategy for the immobilization of antibodies on an ELISA plate using MOFs to 
form an antibody@MOF composite is presented. Pretreatment of the surface of the plate with a 
binding agent is critical to obtain an antibody@MOF layer that is more stable and possess high 
integrity. Therefore, the polystyrene pattern coated with polydopamine-polyethyleneimine 
(PDA-PEI) was utilized to induce the basement for the nucleation of the antibody@MOF 
composite on a polystyrene substrate. PEI contains abundant NH2 groups to covalently 
immobilize PD-L1 antibodies. The Zeolite Imidazolate Framework-8 (ZIF-8) MOF was selected 
based on the following features: (a) biocompatibility and biodegradability (low cytotoxicity); (b) 
low cost and long durability,29, 30 and (c) high stability under experimental conditions (e.g., 
higher temperatures and extremely alkaline and acidic conditions) that are harsher than those 
used for ELISA.31, 32 In this article, we describe a simple method based on ELISA method for the 
development of an inexpensive, rapid and highly-sensitive in vitro diagnostics kit. This proposed 
immobilization approach only encompasses the addition of an antibody to ZIF-8 to form a stable 
complex on the PDA-PEI pattern on the polystyrene surface. The fabricated MOF-based ELISA 
improved the LOD and stability of the conventional ELISA kit under perturbation conditions, 
which demonstrated its potential to significantly improve current immunoassays.
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A microtitre ELISA plate was purchased from FALCON (U.S.A), Human PD-L1 Simple Step 
ELISA® Kit was provided by Abcam (Cat No ab214565, Australia), Tris (hydroxylmethyl) 
aminomethane, dopamine hydrochloride (DA), polyethyleneimine (PEI, Mw=1000 Da), 2-
methylimidazole, phosphate buffered saline (PBS) and zinc nitrate hexahydrate were purchased 
from Sigma–Aldrich (USA).
 Polydopamine coating of polystyrene microtiter ELISA plates
A polystyrene microtiter ELISA plate was coated with a thin layer of PDA-PEI based on a 
previously published protocol.33 A PDA film can form on organic/inorganic surfaces through 
self-polymerization of dopamine under alkaline conditions.34 PEI in the dual polymerization of 
PDA-PEI, endures Michael addition or Schiff-base reactions with a catechol group in PDA to 
produce a strong bio-adhesive layer on the surface of substrate. Therefore, the role of PEI was as 
a cross-linking agent with PDA. 35 Briefly, each well of a microtiter ELISA plate as the model 
substrate was treated with 200 µL of freshly prepared solution of dopamine hydrochloride (2 
mg/mL), PEI (1000 MW, 2 mg/mL) in Tris-buffer solution (0.05 M, pH 8.5). The treated plate 
was incubated overnight at room temperature and washed three times with Milli-Q® water. For 
each experiment, a fresh dopamine hydrochloride solution was used to prevent premature 
polymerization of dopamine. 
Preparation of antibody@ZIF-8 
ZIF-8 was used as a representative MOF structure in this study. ZIF-8 was synthesized through a 
self-assembly process, as previously described 33. Briefly, the ZIF-8 precursor solution was 
prepared from zinc nitrate hexahydrate, Zn(NO3)2·6H2O (0.027 g) and 2-methyl imidazole, 
(0.566 g) in a total volume of 10 mL Milli-Q® water. Both the detector and capture anti-PD-L1 
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antibodies (from Abcam ELISA kit) were provided in 10× concentration and mixed with a ZIF-8 
solution to obtain a 1× concentration, dispensed into the PDA-PEI coated wells, and incubated 
for 60 min at room temperature using a plate shaker. A schematic illustration of the workflow is 
shown in Figure 1. The resultant antibody@ZIF-8/PDA-PEI was used for a highly sensitive 
immunoassay of PD-L1.
Surface characterization
The structure of the antibody@ZIF-8/PDA-PEI was characterized by using microscopy imaging 
and spectroscopic techniques. Scanning electron microscopy (SEM) was used to probe the 
surface morphology of the modified microtiter ELISA plate. The modified surfaces were sputter-
coated with a 15 nm Au/Pd coating under vacuum to achieve a good conductivity. SEM images 
were then taken using a scanning electron microscope (ZEISS SUPRA55VP, USA) with an 
accelerating voltage of 5 keV. The thickness of the ZIF-8 and PDA-PEI on the surface of the 
microtiter ELISA plate was measured by atomic force microscopy (AFM; Park systems XE7). A 
V-shaped cantilever with a frequency of 286.2 kHz was used to capture the surface morphology 
in nonconductive mode. The average values of the roughness were reported to determine the 
surface roughness of the polymer films on a scan area of 5.0 µm × 5.0 µm. The captured 
topographical images were analyzed using ProfilmOnline and Gwyddion 2.55 software.
The chemical composition of the modified microtiter ELISA plate wells was analyzed by 
Fourier-transform infrared spectroscopy (FT-IR) (MIRacle 10, Shimadzu, USA). FT-IR spectra 
were acquired in triplicate in the range of 4000–400 cm−1 with a resolution of 4 cm−1 and 
averaging 16 scans for each spectrum. Furthermore, powder X-ray diffraction (XRD) (D8 
Discover BRUKER) was performed to identify the ZIF-8 crystalline structure on the surface of 
the PDA-PEI-coated microtiter ELISA plate. Crystallographic data of the antibody@ZIF-8/PDA-
PEI patterns was obtained by scanning the sample through a 2θ range of 5–40o with a step size of 
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0.019o and 1 second per step. The XRD data analysis was performed using High Score Plus 
software and compared with the database from the International Center for Diffraction Data.
The water contact angle (WCA) was measured using a drop shape analyzer (DSA 100, Kruss, 
Germany) and One Attension software (14 µL, a geometrical method sessile drop, water, 
formamide, and glycerol). An image of a water droplet on the surface of a microtiter ELISA 
plate, PDA-PEI -coated, and PDA-PEI /ZIF-8-coated surface was captured with a CCD camera. 
The contact angles were calculated by drawing a tangent line near the edge of each droplet; the 
values are reported as the average of three measurements performed at three locations on the 
surface. Additionally, to probe the intermolecular interactions at the interface surface free energy 
(SFE) of a solid was calculated using the Oss and Good acid-base method from the contact angle 
measurement.36
Detection of PD-L1 using the modified ELISA
The detection of the PD-L1 antigen was performed using three different platforms including the 
commercial ELISA kit, modified ELISA in PDA-PEI -coated wells, and modified ELISA using 
antibody@ZIF-8/PDA-PEI. To achieve standard curves, which were defined as the optical 
density (OD) versus the protein concentration, eight concentrations of PD-L1 (0, 21.88, 43.75, 
87.5, 175, 350, 700, and 1400 pg/mL) were prepared and examined using the three 
configurations based on the ELISA protocol. Briefly, the precursors of ZIF-8 were added to the 
microtiter ELISA plate wells coated with PDA-PEI and incubated with both capture and detector 
antibodies for 60 minutes at room temperature. Then, the wells were washed with the washing 
buffer and incubated with 3,3’,5,5’-tetramethylbenzidine (TMB) development solution for 10 
min. Finally, the stop solution was added and the OD was immediately recorded at 450 nm. For 
statistical analysis , the OD measurements were conducted in triplicate. A concentration of 0 
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pg/mL of PD-L1 antigen, which means, no addition of antigen, was used to examine whether the 
PDA-PEI and ZIF-8/PDA-PEI platforms show self-absorbance in the immunoassay. 
 Examining the stability of antibody@ZIF-8 at various pH and temperatures
We hypothesized that MOF can be a powerful class of material for preserving the stability of 
antibodies at various temperatures and pH. To test this hypothesis, the activity of the antibodies 
in both antibody@ZIF-8/PDA-PEI ELISA and commercial ELISA was assessed under different 
pH and temperature conditions. The antibody@ZIF-8 was incubated for 10 min at room 
temperature to form the ZIF-8 crystals around the antibody. The resulting antibody@ZIF-8 
composite and the original antibody as a control were placed in microtubes and subjected to 
various temperatures ranging from 45°C to 85°C at 10°C intervals for 30 min. Then, the PD-L1 
antigen at a concentration of 350 pg/mL was added to each mixture, moved to the microtiter 
ELISA plate well, and incubated for 60 min at room temperature. After incubating with TMB 
and a stop solution, the OD was recorded at 450 nm. 
In order to examine the stability of the antibody@ZIF-8 at various pH, PBS solution with 
different pH values (ranging from 5 to 10 with an increment of 1) were used. Both the capture 
and detector antibody@ZIF-8 mixture was incubated with PD-L1 antigen at a concentration of 
350 pg/mL. The PBS solution with different pH were added to wells and allowed to stand for 60 
min, whereas in the control group, both the capture and detector antibodies without ZIF-8 were 
subjected to various pH treatments. 
The sensitivity measurements
To assess the sensitivity of the MOF-based ELISA, the concentration of the capture and detector 
antibodies was further decreased 20, 100, and 200 times, which we named 0.05x, 0.01x, and 
0.005x, and a PD-L1 ELISA was conducted in three different types of wells, (conventional 
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ELISA, PDA-PEI -coated, and antibody@ZIF-8/PDA-PEI). The LOD was calculated according 
to the standard formula reported in the literature.37, 38
The Sensitivity was calculated by measuring the slope of ELISA standard curve (Absorbance / 
concentration of antibody (absorbance/pg/mL)).
Statistical analysis:
Statistical analysis of ELISA in all three studied platforms including: antibody@ZIF-8/PDA-PEI, 
conventional ELISA in PDA-PEI coated wells and conventional ELISA in exposure to elevated 
temperatures and various pH was performed using T-test in SPSS 22 software. Experiments were 
carried out at least three times.  Statistically significances was measured as the p < 0.05 .
Results and discussions
 Surface characterization 
SEM images showed the morphologies of polystyrene substrate with and without ZIF-8 
precursors are quite distinctive and the PDA-PEI coating formed a dense, thick film above the 
polystyrene microtiter ELISA wells (Figure 2A). The antibody@ZIF-8 platform had the same 
polyhedral morphology as pristine ZIF-8 (Figure 2AI, II) the small size of antibody protein 
makes them invisible at this magnification. Due to the presence of a wide range of functional 
groups in proteins (such as carbonyl, hydroxyl ,carboxyl,  and imidazole groups), they consider  
as nucleation sites for the formation of ZIF-8 crystals.39 Besides, SEM images illustrate that the 
crystal morphology of ZIF-8 uniquely depended on the antibody. These images indicated that the 
microtiter ELISA wells were successfully covered by a hydrophilic PDA-PEI layer. 
The AFM image of the microtiter ELISA well in Figure 2B IV showed the native microtiter 
ELISA well is a flat surface. In comparison, the image displayed in Figure 2B III demonstrated 
that a nano-sized thin film was distributed on the surface uniformly with enhanced roughness 
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after treatment with ZIF-8. Based on Figure 2BII numerous evenly distributed sharp peaks on the 
microtiter ELISA well surface that previously coated with PDA-PEI confirmed the ZIF-8  
formation on the surface. The average values of the roughness of all surfaces were measured by 
atomic force microscopy That sensed the surface roughness of the sampleby a change in the laser 
beam and the deflection of the cantilever,40; thus it can generate  the topography of surface. The 
results were analyzed using Gwyddion 2.55 software, which indicated average roughness values 
of 20.47 nm, 13.22 nm, 5.296 nm, and 180 pm for the antibody@ZIF-8/PDA-PEI, ZIF-8/PDA-
PEI, PDA-PEI, and empty microtiter ELISA wells, respectively. 
 In Figure 2BI the distribution of multiple sharp peaks on the PDA-PEI treated microtiter ELISA 
well surface demonstrated the morphology of antibody@ZIF-8-loaded PDA-PEI treated surface. 
Overall, the observations made from the SEM and AFM images confirmed that both PDA-PEI 
and ZIF-8 could increase the surface roughness and consequently prepare larger surface area for 
PD-L1 antibodies to be immobilized on the ZIF-8/PDA-PEI-derived microtiter ELISA well 
surface, which is suitable for the formation of a sandwich-type ELISA format.
The functional groups present in the structures of PDA-PEI and ZIF-8 were identified using FT-
IR (Figure 3A). Strong bands at 3135, 2929, 1635, 1585, 1510, 1367, 1333, 1146 and 426 cm−1 
were observed in the FT-IR spectrum of the ZIF-8 sample after formation of ZIF-8 on the PDA-
PEI patterning. The peaks detected at 3135 and 2929 cm−1 were attributed to aromatic and 
aliphatic C–H asymmetric stretching vibrations, respectively. The signal at approximately 1635 
cm−1 was attributed to the C C stretching mode, whereas the band at 1585 cm−1 corresponded to 
the C N stretch vibration. The peaks at 1300–1460 cm−1 and 1146 cm−1were attributed to the 
entire aromatic ring stretching, and aromatic C–N stretching mode, respectively. Interestingly, a 
sharp Zn–N stretching vibration band was observed at 426 cm−1, which suggested the formation 
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of an imidazolate through the chemical combination of zinc ions and nitrogen atoms of the 
methyl imidazole groups.41 The FT-IR spectrum of the surface modified with PDA-PEI 
patterning contained a peak in the 1510–1560cm−1 range, which was attributed to N–H 
vibrations, and a peak between 3200–3400 cm−1, which indicated the presence of hydroxyl 
groups. The FT-IR spectrum of the antibodies@ZIF-8 contained stretches at 1530 cm−1 owing to 
the presence of antibodies, which corresponded with the characteristic amide II band (mainly 
from a combination of NH bending and CN stretching modes). Furthermore, in the FT-IR 
spectrum of antibodies@ZIF-8/PDA-PEI, shifting the amide vibrational mode for the antibodies 
to a higher wave number indicated strong interactions between the antibody and the ZIF-8 due to 
the coordination between the Zn cations and the carbonyl group of the protein. The characteristic 
ZIF-8 peak at 426 cm−1 was also observed in the antibodies@ZIF-8/PDA-PEI, confirming the 
formation of a ZIF-8 structure. The FT-IR results for ZIF-8 and antibody@ZIF-8 were consistent 
with the results of Feng et al., showing the presence of the same functional group.42 Moreover, 
Mohammad and co-workers reported similar FT-IR peaks for PDA-PEI patterning.33 
The XRD pattern of ZIF-8/PDA-PEI consisted of a broad peak owing to the presence of 
amorphous PDA-PEI. The XRD pattern was consistent with the dominant sharp peaks displayed 
by simulated ZIF-8 patterns;43 additionally for antibody@ZIF-8/PDA-PEI, the discrete peaks 
recognized were at 2θ of 18.02° , 12.7°, 10.3° and 7.3°,  corresponding to 222, 211, 200 and 110, 
orientations, respectively (Figure 3B). These results prove the existence of crystal structure of 
ZIF-8.
Changing the surface chemistry and microstructure could tuned the wetting properties of a 
surface The calculated WCAs and the corresponding SFEs of the modified surfaces are shown in 
Figure 3C. The WCA of polystyrene significantly reduced from 65.77° to 54.23° after the PDA-
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PEI patterning, whereas the SFE increased from 47.2 mN/m to 61.7 mN/m. We attributed these 
changes to the changes in the surface chemistry owing to the higher number of the catechol 
group, which increased the surface chemical attraction to molecules of water and enhanced the 
hydrophilicity. The increase in the hydrophilicity after the introduction of the PDA-PEI coating 
was due to the chemical nature of the PDA layer. Mohammad et al.33 also reported enhancement 
of the hydrophilicity after coating an ELISA plate with PDA-PEI. It has been shown that an 
increase in roughness results in increasing hydrophilicity.44 Our results demonstrated that the 
formation of ZIF-8 and antibody@ZIF-8/PDA-PEI thin films slightly decreased the WCA from 
65.77° in polystyrene to 25.14° and 30.48° in ZIF-8 and antibody@ZIF-8/PDA respectively. The 
change in WCA that make the patterning much more hydrophilic was owing to the ZIF-8 layer 
formation, which increased the surface rugosity. Wenzel explained the effect of morphology and 
surface chemistry on the WCA using the following equation (Eq. 1).45
Cos θ = r Cos θe   (1)
in which θe is the WCA on a flat surface, θ is the apparent contact angle, and r is the ratio of the 
actual solid/liquid contact area to its vertical projection. An increase in roughness enhances the 
value of r and results in hydrophilicity. The hydrophilicity resulting from the PDA and ZIF-8 
coating led to better absorption of droplets (e.g., antibody) to the surface.44
High thermal and pH stability of antibody@ZIF-8
The bio-mineralization of ZIF-8 was owing to the enrichment of precursors on the PDA-PEI-
coated wells, which possesses hydrophilicity properties, followed by the chelation of the zinc ion 
precursors on the surface with the catechol moiety in PDA.46 This enabled the spontaneous ZIF-8 
growth above the PDA-PEI coating.47-49 The ability of MOFs to preserve the stability of proteins 
and antibodies is attributed to the tight encapsulation of proteins, which resulted from the small 
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pore size of the MOF and the coordination interactions between the Zn cations of ZIF-8 and the 
carbonyl groups of the protein backbone .39 The loading of biomacromolecules in the pore 
networks of MOFs could potentially protect them from the outer environment. Moreover, it has 
been demonstrated that the MOF pore structure not only maintains the activity of stored 
biomolecules but also improves their activity through the self-assembly (biomineralization) 
process.26 The results indicated that after heating treatments, the unprotected antibody lost its 
main activity in ELISA whereas antibody@ZIF-8 maintained its biological activity up to 55°C 
(Figure 4A). The activity of the antibody@ZIF-8 decreased when the temperature was increased 
to 65°C. However, the antibody@ZIF-8 structure still showed a higher OD at 65°C compared 
with the standard ELISA either in empty wells or PDA-PEI -coated wells. The effect of the 
PDA-PEI coating on the protein stability at various temperatures was much lower than ZIF-
8/PDA-PEI; however, its detected OD was still higher than that in commercial ELISA wells. 
Results of ELISA using antibody@ZIF-8/PDA revealed that by increasing the temperature, the 
detected OD using the antibody@ZIF-8/PDA platform ELISA will be decreased. However, this 
reduction compares to that of PDA-PEI coated well ELISA and conventional ELISA was not 
significant (p value=0.22). To explain quantitatively, the detected OD in conventional ELISA in 
exposure to elevated temperature (45ºC) showed a dramatic decrease from 0.8 to 0.2, and by 
increasing the temperature to 55ºC, it decreased to 0.17, which is the confirmation for the loss of 
antibody bioactivity. Similarly, in ELISA performed on PDA-PEI coated wells, detected OD in 
exposure to elevated temperature (45ºC) showed a sharp decrease from 2 to 0.3, and by 
increasing the temperature to 55ºC, it decreased to 0.2, which is the confirmation of the loss of 
antibody bioactivity. However, in antibody@ZIF-8/PDA-PEI platform ELISA the detected OD 
in exposure to elevated temperature (45ºC) showed a slight decrease from 2.55 to 2.4. By 
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increasing the temperature to 55ºC, it decreased to 2, which is confirmation of the antibody 
stability in elevated temperature. However, when the temperature increased to 65ºC, the OD was 
decreased dramatically to 0.2, which proves the loss of antibody bioactivity (Figure 4A).  
Similarly, the results clearly proved the stable behavior of antibody@ZIF-8 when exposed to 
various pH from 5 to 10. The ability of the PDA-PEI coating to maintain the antibody activity at 
various pH was much lower than ZIF-8; nonetheless, its activity was still higher than the activity 
of antibodies in commercial ELISA wells (Figure 4B). To explain quantitatively, the detected 
OD in conventional ELISA in exposure to pH=5 showed a dramatic decrease from 0.8 to 0.15, 
and by increasing the pH to 10, the OD decreased to 0.07, which proves the antibody lost its 
bioactivity. Moreover, in ELISA performed using antibody@ZIF-8/PDA-PEI platform, the 
detected OD in exposure to pH=5 showed a slight decrease from 2.55 to 2.04, and by increasing 
the pH to 10, the OD decreased to 1.1 that is confirmation of the antibody stability in acidic and 
alkaline condition (Figure 4B). The reduction of the OD in the antibody@ZIF-8/PDA ELISA, in 
exposure to various pH compare to that of PDA-PEI coated wells ELISA and conventional 
ELISA was not significant (p value=0.14).  Feng et al.42 showed that protecting antibodies with 
ZIF-8, ZIF90, and ZIF8X resulted in extraordinary thermal, chemical, and mechanical stabilities. 
The results in our study indicate that ZIF-8 is a protective agent for biological molecules, which 
was consistent with the results reported by Feng et al. Furthermore, the novel use of MOF for 
biomineralization of an antibody improved the LOD in an ELISA assay. Tan and co-workers50 
demonstrated similar results by replacing the antibody-conjugated enzymes in ELISA with 
antibody-covered Cu3(PO4)2@PDA nanosheets. They revealed that a high number of attached 
antibodies to the flat nanosheets resulted in a low detection limit. They also proved the antibody-
covered Cu3(PO4)2@PDA nanosheets were stable under conditions that are usually not favorable 
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to enzymatic activity. In another report, Mohammad et al.33 employed a mussel-inspired PDA-
PEI coating to pattern horseradish peroxidase (HRP) and glucose oxidase (GOx)-ZIF-8 in 
microfluidic channels. Their results indicated that in situ ZIF-8/GOx&HRP composites prepared 
on PDA-PEI patterns showed a higher acidic and thermal stability compared to the samples 
without ZIF-8. More recently, Zhang and co-workers51 developed a MOF delivery system 
through the encapsulation of CpG oligodeoxynucleotides (ODNs) into ZIF-8 nanoparticles. Their 
results emphasize the high stability of ZIF-8/CpG ODNs complexes in various physiological 
environments. Furthermore, Wang et al.52 were able to maintain the biorecognition capabilities 
of antibodies exposed to increased temperatures (40 and 60°C) by using MOF coatings of 
antibodies (IgG/anti-IgG) to immobilize them on sensor surfaces. In the present study, we 
successfully immobilized antibodies on the surface of microtitre ELISA plates using a simple 
one-step cost-effective material to improve the LOD of conventional ELISA kit by 225 times and 
examined their stability at elevated temperatures and a wide pH range to confirm their heat, 
acidic, and alkaline stability. The configuration used in this work eliminates the need for strict 
storage conditions for antibodies and preserves the biofunctionality of antibodies in harsh 
environmental conditions. In another study, Liao and co-workers24 integrated catalase (CAT) 
enzyme in ZIF-90 and ZIF-8 microcrystals and showed the enzyme maintained its biological 
features in a broader variety of conditions, including high temperatures (i.e., 80°C) and addition 
of denaturing reagent (i.e., urea). 
Antibody@ZIF-8 improved LOD and sensitivity of ELISA
We anticipated that the present PDA-PEI - and antibody@ZIF-8/PDA-PEI -coating method 
would improve the LOD of the immunoassay. The LOD on the PDA-PEI -coated wells (0.313 
pg/mL) and antibody@ZIF-8/PDA-PEI -coated wells (0.035 pg/mL) improved 25 times and 225 
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times, respectively, compared with that of the commercial ELISA kit (7.89 pg/mL). Liu et al.53 
used a MOF-based sandwich ELISA system for the detection of alpha-fetoprotein (AFP), a 
biomarker for liver cancer, however they modified their wells using PEI which could detect 0.02 
ng/mL AFP in blood. In the present study the further modification on PDA-PEI coated surface 
with ZIF-8 leads to thousand time improvement in the LOD compare with their study. Our 
proposed coating methods improved the detection limit of the PD-L1 immunoassay 25 times, 
which is much higher than that recently reported by Wang et al..54 They integrated the rabbit 
anti-mouse immunoglobulin G antibody (RIgG) with Cu-MOF with peroxidase-like activity 
(RIgG@Cu-MOF) for colorimetric immunoassay detection of mouse IgG (mIgG) in serum. The 
limit of detection of RIgG@Cu-MOF toward mIgG was 0.34 ng/mL which was 3 times more 
sensitive than that of horseradish-peroxidase-labeled RIgG. Additionally, they reported a similar 
stability against pH, high temperature, and long-time storage, using different types of MOFs. 
The sensitivity of the antibody@ZIF-8/PDA-PEI ELISA was also studied. The sensitivity of 
antibody@ZIF-8/PDA-PEI was measured as the value of absorbance over the antibody 
concentration 33, 55. The sensitivity of antibody@ZIF-8/PDA-PEI was linear when examined in a 
low concentration antibody (ranging from 0, 21.88, 43.75, 87.5, and 175 to 350 pg/mL). The 
ELISA performed using the antibody@ZIF-8/PDA-PEI platform had a higher sensitivity of 
0.0862 absorbance/pg/mL compared with the ELISA performed in wells coated with PDA-PEI 
(0.0424 absorbance/pg/mL) and conventional ELISA (0.005 absorbance/pg/mL; Figure 4D). 
This indicated 15.12 and 7.4 times higher sensitivity of the antibody@ZIF-8/PDA-PEI and PDA-
PEI platforms, respectively, compared with conventional ELISA. Our platform also showed 
(Figure 4C) that even after decreasing the number of antibodies 200 times; we were still able to 
obtain the same efficient results as the standard antibody used for ELISA. This makes this 
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technology more versatile and cost-effective for ELISA and other techniques that use protein and 
antibody immobilization for biomarker detection. Results of this study showed higher 
improvement in LOD (225- fold) compare to other published MOF-based ELISA methods54, 56, 
57. The MOF-based ELISA techniques and other metal and metal oxide-based techniques to 
improve the LOD of conventional ELISA have been listed in Table 1 and elsewhere13. 
The ELISA results of three different well configurations, commercial ELISA wells, PDA-PEI -
coated wells, and PDA-PEI /ZIF-8 coated wells, indicated that the OD in antibody@ZIF-8 wells 
was higher than that in the PDA-PEI -coated wells, and much higher than that in commercial 
ELISA wells. These results proved our hypothesis that the ZIF-8/PDA-PEI configuration 
increased the sensitivity of the immunoassay (Figure 4C). Moreover, both configurations 
including the PDA-PEI -coated and ZIF-8/PDA-PEI -coated wells did not show any measurable 
OD in the absence of the PD-L1 antigen, which confirmed that there was not any false-positive 
absorbance.
We proposed a protective coating approach based on MOFs to proficiently improve the LOD of 
current ELISAs and also protect antibodies against perturbation environments. To the best of our 
knowledge, this is the first time that a MOF coating has been used to improve the LOD of a 
commercial ELISA kit. There are three major factors that could contribute to the enhancement of 
the LOD and sensitivity of the antibody@MOF in a commercial ELISA kit: 1) The antibody 
could adsorb physically to the polystyrene surface by interacting with the hydrophobic groups 
exist in antibody molecules without requirements for ZIF-8/PDA-PEI. A higher Ab 
immobilization density could be reached on this platform to promote improved the physical 
adsorption of the antibody onto the polystyrene surface because of the increase in surface 
roughness, which provides a larger surface area. The higher surface area results in higher 
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absorption and detection. 2) This platform not only provides the specific orientation for 
immobilized antibodies owing to the reduction of steric hindrance and tight confinement of the 
antibodies, but it also inhibits the random and upside down orientation of the antibody, which 
increases the exposure of the antibody’s antigen binding fragment to a higher amount of 
antigens. 3) The hydrophilicity of the surface is improved as a result of coating with PDA-PEI, 
which would be beneficial for capturing of antibodies. 
 
Conclusions
A MOF-based sandwich immunoassay was developed for highly sensitive detection of human 
PD-L1 antigen using modified ELISA. The antibody@MOF was highly stable against elevated 
temperature and pH, as indicated by no decrease in the detection response when it was exposed 
to a pH range of 5-10 and a temperature up to 55°C. The proposed method resulted in an LOD of 
0.035 pg/mL and 0.313 pg/mL in antibody@ZIF-8/PDA-PEI and PDA-PEI -coated 
configurations, which was 225 and 25 times more sensitive than conventional ELISA, 
respectively. The developed immunoassay had a 15.12-fold higher sensitivity compared with the 
commercially available ELISA, which represent significant potential for the future development 
of in vitro diagnostic kits and immunoassays that are highly sensitive for various disease 
biomarkers and analytes.
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Figure 1. The workflow of the surface modification for the immunoassay using a PDA-PEI and 
ZIF-8 platform and their stability against high temperature and various pH. The microtitre 
ELISA plate coated with thin layer of PDA-PEI and the anti PD-L1 antibody was added in to 
precursors of ZIF-8, following the addition of the certain concentration of PD-L1 antigen and 
incubate for 1 hour in room temperature on 400 rpm plate shaker. The stability of proposed 
platform against elevating pH and temperature was also investigated during incubation time.
Figure 2. (A) SEM images of (I) antibody@ZIF-8/PDA-PEI, (II) ZIF-8/PDA-PEI, (III) PDA-
PEI coated well, (IV) empty well with 5000x magnification (Scale bar: 2 µm). The thin film of 
PDA/PEI formed on the surface of microtiter ELISA wells. (B) AFM images of (I) empty well, 
(II) PDA-PEI coated well, (III)ZIF-8/PDA-PEI , (IV)antibody@ZIF-8/PDA-PEI. Surface 
roughness increases by formation of thin film of ZIF-8 on the surface of PDA-PEI coated wells.
Figure 3. (A) FT-IR spectra of antibody@ZIF-8/PDA-PEI, ZIF-8/PDA-PEI, PDA-PEI coated 
well and  Empty well. Measurements were done from 4000 to 400 cm-1 and PDA-PEI showed 
intensive peak at 1650cm-1 whilst ZIF-8 have important peak at 426cm-1. (B)XRD patterns of 
antibody@ZIF-8/ PDA-PEI, ZIF-8/PDA-PEI, PDA-PEI coated well and Empty well. The 
intensive peaks in 7.3, 10.3, 12.7, 16.5, 18 which is specific for ZIF-8 crystalline structure proves 
the dense formation of ZIF-8 crystalline layer on surface of microtitre ELISA plate. (C)Water 
Contact Angle and Surface Free Energy of antibody@ZIF-8/ PDA-PEI, ZIF-8/PDA-PEI, PDA-
PEI coated well and  Empty well.
Figure 4. ELISA for detection of PD-L1 antigen in exposure to various (A) temperatures and (B) 
pH and (C Standard Curve for PD-L1 antigen in PDA-PEI coated wells, antibody@ZIF-8 in 
PDA-PEI coated wells and empty wells. (D) The effect of decreasing antibody concentration on 
OD detection. Up to the concentration of 350pg/mL of PD-L1 antigen the detection graph was 
linear. The lines show linear trend line.  
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Table 1. The comparison of using ZIF-8/PDA-PEI platform with other MOF, metal, and metal oxide-based 
platforms for ELISA in the literature.
Types of 














20-2000 pg/mL 0.8 
pg/mL
10-fold 58
Gold nanoparticle Colorimetric C reactive protein 0.1 – 1000 ng/mL 0.1 ng/mL 100-fold
59
Magnetic 




















Cu-MOF Colorimetric mIgG 1 – 100ng/mL 0.34ng/mL 3-fold
54
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